Korea Aims To Nurture Device Sector With Four-Point Plan
This article was originally published in The Gray Sheet
South Korea has released a new strategic plan to support the development of promising medical devices. The measures, which come after a similar grand strategy was released for the biomedicine sector, include plans to fund support new R&D projects, increase clinical trial support centers and designate innovative device firms.
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.